Bupropion SR vs. Placebo for Weight Loss in Obese Patients with Depressive Symptoms
Obesity Research2002Vol. 10(10), pp. 1049–1056
Citations Over TimeTop 10% of 2002 papers
Adesh K. Jain, Roy A. Kaplan, Kishore M. Gadde, Thomas A. Wadden, David B. Allison, Edwin R. Brewer, Robert A. Leadbetter, Nathalie Richard, Barbara R. Haight, Brenda D. Jamerson, Kathleen S. Buaron, Alan Metz
Abstract
Bupropion SR in combination with a 500 kcal/d-deficit diet facilitated weight loss. Weight loss of > or =5% may improve mood in obese patients with depressive symptoms.
Related Papers
- → Behavioral Transitions and Weight Change Patterns Within the PREMIER Trial(2011)42 cited
- → Short-term weight changes in community-dwelling older adults: the Health, Aging, and Body Composition Weight Change Substudy(2005)17 cited
- → Short-term weight changes in community-dwelling older adults: the Health, Aging, and Body Composition Weight Change Substudy(2005)24 cited
- → The association of COMT genotype with buproprion treatment response in the treatment of major depressive disorder(2020)4 cited
- → Patterns of Weight Change in a Commercial Weight Loss Program(2021)2 cited